Atorvastatin Calcium
NDC 71209-091, Atorvastatin Calcium, tablet, coated, from Cadila Pharmaceuticals Limited.
- Product NDC
- 71209-091
- Status
- Listed
- Labeler
- Cadila Pharmaceuticals Limited
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA212103
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/71209-091 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ATORVASTATIN CALCIUM TRIHYDRATE20 mg/1
Pharmacologic classes
HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 71209-091-04 | 71209009104 | 90 TABLET, COATED in 1 BOTTLE (71209-091-04) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/51730b09-24e8-41c8-9fec-813f8a64b433
Use it
Look up 71209-091 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/71209-091 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 71209-091. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.